Omission of postoperative radiotherapy after breast-conserving surgery in low-risk breast cancer
Sofia Palmér(Örebro University), Kenneth Villman(Örebro University Hospital), Fredrika Killander(Lund University), Johan Ahlgren(Uppsala University), Zakaria Einbeigi, Henrik Lindman(Uppsala University), Antonios Valachis(Örebro University Hospital), Judith Bjöhle(Karolinska University Hospital), Daniel R. Smith(Örebro University), Greger Nilsson(Turku University Hospital), Åsa Wickberg(Örebro University)
Cited by 2
Related Papers
Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment
|PLoS ONE|2009|504
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial
|The Lancet|2000|343
Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [<sup>68</sup>Ga]ABY-025 Affibody PET/CT
|Theranostics|2015|269
First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the <sup>111</sup>In-ABY-025 Affibody Molecule
|Journal of Nuclear Medicine|2014|260